Emerging studies suggest Retatrutide , a dual agonist targeting both the gut-brain axis and another hormone, could represent a notable advancement for obesity management . Initial human tests have https://bookmarkblast.com/story21510329/a-retatrutide-compound-the-breakthrough-in-weight-management